Last Price
11.78
Today's Change
+1.49 (14.48%)
Day's Change
11.20 - 12.37
Trading Volume
726,879
Market Cap
582 Million
Shares Outstanding
49 Million
Avg Volume
157,554
Avg Price (50 Days)
8.60
Avg Price (200 Days)
8.12
PE Ratio
-6.56
EPS
-1.79
Earnings Announcement
07-Nov-2024
Previous Close
10.29
Open
11.45
Day's Range
11.202 - 12.3782
Year Range
5.99 - 12.3782
Trading Volume
734,288
1 Day Change
14.19%
5 Day Change
40.38%
1 Month Change
23.04%
3 Month Change
33.22%
6 Month Change
66.43%
Ytd Change
30.12%
1 Year Change
37.91%
3 Year Change
-20.61%
5 Year Change
-20.61%
10 Year Change
-20.61%
Max Change
-20.61%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.